Category: Stryker Corp.
Sunshine Heart raises $1.5 million of a hoped-for $25.5 million equity funding round.
Eden Prairie, Minn., and Sydney-based medical device company Sunshine Heart (ASX:SHC) is looking to raise funds in a $25.5 million equity funding round, according to document filed with the SEC earlier this month.
Stryker (NYSE:SYK) CEO Kevin Lobo told an investors conference audience in Las Vegas yesterday that the medical device company is still in the mergers & acquisitions hunt, even after its newsmaking buyouts of China's Trauson Holdings, Israel's Orthovita and Surpass Medical.
Changing expectations affect investors despite unchanged fundamentals: Weaker underlying volumes.
By Stephen Simpson
Stryker Corp.'s 1st-quarter profits fall 13% on costs from the recall of its Rejuvenate and ABG II hip implants and a U.S. Justice Dept. probe into the marketing of its OtisKnee implant.
Stryker (NYSE:SYK) said the recall of some of its hip implant components and a U.S. Justice Dept. probe into its OtisKnee device helped push 1st-quarter profits down 13%, but still managed to beat Wall Street analysts' expectations.
Kalamazoo, Mich.-based Stryker posted profits of $304 million, or 79¢ per share, on sales of $2.19 billion during the quarter, amounting to 1.3% sales growth.
FDA regulators slap Class I status on Stryker's ShapeMatch knee surgery cutting guide recall over concerns that the devices may not have been manufactured according to established standards.
The FDA slapped its highest-risk classification on orthopedic titan Stryker's (NYSE:SYK) ShapeMatch recall, warning that the devices may not have been manufactured properly.
The issue was picked up via post-market surveillance of product complaints, according to the federal watchdog agency.
Dentsply details its plans to replace ex-CFO William Jellison, who jumped ship ater 15 years for medical device company Stryker.
Dentsply International (NSDQ:XRAY) detailed its plans to replace ex-CFO William Jellison, who jumped ship today for medical device company Stryker (NYSE:SYK).
Stryker Corp. names Dentsply CFO William Jellison to be its new CFO, replacing interim finance chief Dean Bergy.
Medical device company Stryker (NYSE:SYK) said it hired William Jellison, the finance chief for Dentsply International (NSDQ:XRAY), to be its new CFO.
